Acute myeloid leukemia and the infectious diseases consultant

References

• Cannas G, Pautas C, Raffoux E, et al. Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial. Leuk Lymphoma. 2012;53:1068–1076.
   PubMed Web of Science ®Google Scholar
• Sung L, Buxton A, Gamis A, et al. Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children’s Oncology Group. J Pediatr Hematol Oncol. 2012;34:e30–e35.
   PubMed Web of Science ®Google Scholar
• Even C, Bastuji-Garin S, Hicheri Y, et al. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study. Haematologica. 2011;96:337–341.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52:e56–e93.
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.
   PubMed Web of Science ®Google Scholar
• Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50:405–415.
   PubMed Web of Science ®Google Scholar
• Rice LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. Clin Infect Dis. 2008;46:491–496.
   PubMed Web of Science ®Google Scholar
• Evans SE, Ost DE. Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med. 2015;21:260–271.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP. Rational approach to pulmonary infiltrates in leukemia and transplantation. Best Pract Res Clin Haematol. 2013;26:301–306.
   PubMed Web of Science ®Google Scholar
• Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol. 2001;19:253–259.
   PubMed Web of Science ®Google Scholar
• Tangden T, Cars O, Melhus A, et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54:3564–3568.
   PubMed Web of Science ®Google Scholar
• Paltansing S, Vlot JA, Kraakman ME, et al. Extended-spectrum beta-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013;19:1206–1213.
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Arnold R, Gastmeier P. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol. 2014;15:e606–e619.
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Rovira M, Maertens J, et al. Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study. Haematologica. 2010;95:1762–1768.
   PubMed Web of Science ®Google Scholar
• Martino R, Parody R, Fukuda T, et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2006;108:2928–2936.
   PubMed Web of Science ®Google Scholar
• Georgiadou SP, Lewis RE, Best L, et al. The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Bone Marrow Transplant. 2013;48:141–143.
   PubMed Web of Science ®Google Scholar
• El Boghdadly Z, Oran B, Jiang Y, et al. Pretransplant chest computed tomography screening in asymptomatic patients with leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2017;52:476–479.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Zappasodi P, Mancini V, et al. Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel). Ann Hematol. 2016;95:1955–1963.
   PubMed Web of Science ®Google Scholar
• Olofsson SK, Cars O. Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis. 2007;45(Suppl 2):S129–S136.
   PubMed Web of Science ®Google Scholar
• Ambrose PG, Bhavnani SM, Rubino CM, et al. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it’s not just for mice anymore. Clin Infect Dis. 2007;44:79–86.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Lomaestro BM, Drusano GL. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2006;26:1320–1332.
   PubMed Web of Science ®Google Scholar
• Burgess DS. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections. Clin Infect Dis. 2005;40(Suppl 2):S99–S104.
   PubMed Web of Science ®Google Scholar
• Whaley SG, Berkow EL, Rybak JM, et al. Azole antifungal resistance in Candida albicans and emerging Non-albicans Candida species. Front Microbiol. 2016;7:2173.
   PubMed Web of Science ®Google Scholar
• Jung DS, Farmakiotis D, Jiang Y, et al. Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerg Infect Dis. 2015;21:1942–1950.
   PubMed Web of Science ®Google Scholar
• Wang E, Farmakiotis D, Yang D, et al. The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J Antimicrob Chemother. 2015;70:2362–2368.
   PubMed Web of Science ®Google Scholar
• Farmakiotis D, Kyvernitakis A, Tarrand JJ, et al. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. Clin Microbiol Infect. 2015;21:79–86.
   PubMed Web of Science ®Google Scholar
• Park WB, Kim NH, Kim KH, et al. The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis. 2012;55:1080–1087.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Raad I, Patterson TF, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis. 2007;44:2–12.
   PubMed Web of Science ®Google Scholar
• Mulanovich V, Lewis RE, Raad II, et al. Random plasma concentrations of voriconazole decline over time. J Infect. 2007;55:e129–e130.
   PubMedGoogle Scholar
• Sadarangani SP, Estes LL, Steckelberg JM. Non-anti-infective effects of antimicrobials and their clinical applications: a review. Mayo Clin Proc. 2015;90:109–127.
   PubMed Web of Science ®Google Scholar
• Adwan MH. Voriconazole-induced periostitis: a new rheumatic disorder. Clin Rheumatol 2016;36:609–615.
   PubMed Web of Science ®Google Scholar
• Alkan Y, Haefeli WE, Burhenne J, et al. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. Clin Infect Dis. 2004;39:e49–e52.
   PubMed Web of Science ®Google Scholar
• Romano A, Viola M, Gueant-Rodriguez RM, et al. Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med. 2007;146:266–269.
   PubMed Web of Science ®Google Scholar
• Taylor JJ, Estes LL, Wilson JW. Linezolid and serotonergic drug interactions. Clin Infect Dis. 2006;43:1371.
   PubMed Web of Science ®Google Scholar
• Lapi F, Wilchesky M, Kezouh A, et al. Fluoroquino-lones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis. 2012;55:1457–1465.
   PubMed Web of Science ®Google Scholar
• Mulanovich VE, Huband MD, McCurdy SP, et al. Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization. J Antimicrob Chemother. 2010;65:2001–2004.
   PubMed Web of Science ®Google Scholar
• Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant gram-negative bacteremia. J Infect. 2014;69:216–225.
   PubMed Web of Science ®Google Scholar
• Walraven CJ, Lee SA. Antifungal lock therapy. Antimicrob Agents Chemother. 2013;57:1–8.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.
   PubMed Web of Science ®Google Scholar
• Ojeda-Uribe M, Herbrecht R, Kiefer MH, et al. Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin. Acta Haematol. 2010;124:98–102.
   PubMed Web of Science ®Google Scholar
• Rapidis AD. Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon. Clin Microbiol Infect. 2009;15(Suppl 5):98–102.
   PubMed Web of Science ®Google Scholar
• John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect. 2005;11:515–517.
   PubMed Web of Science ®Google Scholar
• Savva-Bordalo J, Pinho Vaz C, Sousa M, et al. Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2012;47:1095–1098.
   PubMed Web of Science ®Google Scholar
• Price TH, Boeckh M, Harrison RW, et al. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood. 2015;126:2153–2161.
   PubMed Web of Science ®Google Scholar
• Atallah E, Schiffer CA. Granulocyte transfusion. Curr Opin Hematol. 2006;13:45–49.
   PubMed Web of Science ®Google Scholar
• Safdar A, Shelburne SA, Evans SE, et al. Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin Drug Saf. 2009;8:435–449.
   PubMed Web of Science ®Google Scholar
• Le J, Ashley ED, Neuhauser MM, et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2010;30:562–584.
   PubMed Web of Science ®Google Scholar
• Ewig S. Nosocomial pneumonia: de-escalation is what matters. Lancet Infect Dis. 2011;11:155–157.
   PubMed Web of Science ®Google Scholar
• Ariza-Heredia EJ, Kontoyiannis DP. Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses. 2014;57:336–341.
   PubMed Web of Science ®Google Scholar
• Bancillon A, Leblanc T, Baruchel A, et al. Study of tolerance and effectiveness of a varicella vaccine in leukemic children. Nouv Rev Fr Hematol. 1991;33:555–556.
   PubMedGoogle Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–292.
   PubMed Web of Science ®Google Scholar
• Forsblom E, Ruotsalainen E, Ollgren J, et al. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2012;56:527–535.
   PubMed Web of Science ®Google Scholar
• Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16:1783–1788.
   PubMed Web of Science ®Google Scholar
• Pragman AA, Kuskowski MA, Abraham JM, et al. Infectious disease consultation for Staphylococcus aureus bacteremia improves patient management and outcomes. Infect Dis Clin Pract (Baltim Md). 2012;20:261–267.
   PubMedGoogle Scholar
• Granwehr BP, Kontoyiannis DP. The impact of infectious diseases consultation on oncology practice. Curr Opin Oncol. 2013;25:353–359.
   PubMed Web of Science ®Google Scholar
• Pongas G, Hamilos G, Rolston KV, et al. Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful. Support Care Cancer. 2012;20:261–265.
   PubMed Web of Science ®Google Scholar
• McQuillen DP, Petrak RM, Wasserman RB, et al. The value of infectious diseases specialists: non-patient care activities. Clin Infect Dis. 2008;47:1051–1063.
   PubMed Web of Science ®Google Scholar
• Shelburne SA, Ajami NJ, Chibucos MC, et al. Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction: a case report of a leukemic patient with invasive mucormycosis. PLoS One. 2015;10:e0139851.
   PubMed Web of Science ®Google Scholar